Stifel Financial’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,513
Closed -$18K 3579
2025
Q3
$18K Buy
+10,513
New +$33.4K ﹤0.01% 3518
2024
Q2
Sell
-524
Closed -$34.9K 3372
2024
Q1
$34.9K Sell
524
-4
-0.8% -$299 ﹤0.01% 3279
2023
Q4
$59.9K Buy
+528
New +$55.1K ﹤0.01% 3214
2023
Q3
Sell
-555
Closed -$203K 3293
2023
Q2
$203K Sell
555
-4
-0.7% -$1.81K ﹤0.01% 3046
2023
Q1
$372K Sell
559
-6
-1% -$5.33K ﹤0.01% 2682
2022
Q4
$495K Buy
565
+138
+32% +$174K ﹤0.01% 2477
2022
Q3
$469K Buy
427
+179
+72% +$236K ﹤0.01% 2475
2022
Q2
$206K Sell
248
-14
-5% -$14.4K ﹤0.01% 2980
2022
Q1
$405K Sell
262
-13
-5% -$17.5K ﹤0.01% 2691
2021
Q4
$493K Buy
275
+77
+39% +$206K ﹤0.01% 2593
2021
Q3
$652K Sell
198
-5
-2% -$17.5K ﹤0.01% 2425
2021
Q2
$891K Buy
203
+64
+46% +$253K ﹤0.01% 2187
2021
Q1
$674K Buy
+139
New +$784K ﹤0.01% 2286

Other funds holding BNGO

Stifel Financial's BNGO Position: Q4 2025 in Review

Stifel Financial sold out of Bionano Genomics (BNGO) in Q4 2025, closing a stake of 10,513 shares — an estimated $18K sold.

Stifel Financial first reported a position in BNGO in Q1 2021 and held it in 13 quarters. The position peaked at $891K in Q2 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q4 2025.

  • Stifel Financial reported no remaining Bionano Genomics position as of Q4 2025 after selling out during the quarter.
  • Stifel Financial sold 10,513 Bionano Genomics shares in Q4 2025, an estimated $18K.
  • Stifel Financial first reported a position in Bionano Genomics in Q1 2021 and held it in 13 quarters.
  • Stifel Financial's Bionano Genomics position peaked at $891K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2025.

Based on Stifel Financial's 13F filing for Q4 2025, filed 13 Feb 2026.